ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 268 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,413,848 | +166.2% | 92,876 | +193.0% | 0.05% | +92.0% |
| Q1 2024 | $906,677 | -9.7% | 31,702 | -3.4% | 0.02% | -24.2% |
| Q4 2023 | $1,004,476 | -67.3% | 32,826 | -71.3% | 0.03% | -72.0% |
| Q3 2023 | $3,074,815 | +212.1% | 114,433 | +314.2% | 0.12% | +218.9% |
| Q2 2023 | $985,142 | +69.0% | 27,626 | +20.4% | 0.04% | +54.2% |
| Q1 2023 | $582,828 | – | 22,946 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |